ImportRefusal LogoImportRefusal

STRIDES ARCOLAB LIMITED

⚠️ Moderate Risk

FEI: 3004612674 • Mumbai, Maharashtra • INDIA

FEI

FEI Number

3004612674

📍

Location

Mumbai, Maharashtra

🇮🇳

Country

INDIA
🏢

Address

201 Devavrata, , Mumbai, Maharashtra, India

Moderate Risk

FDA Import Risk Assessment

36.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
4
Unique Violations
6/14/2016
Latest Refusal
7/11/2007
Earliest Refusal

Score Breakdown

Violation Severity
78.0×40%
Refusal Volume
17.7×30%
Recency
0.0×20%
Frequency
2.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

38471×

FDF4APIGMP

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods and controls used in its manufacture and control do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B). This finished dosage form drug is made using an Active Pharmaceutical Ingredient from a facility that has been found non-compliant with current Good Manufacturing Practice (see Import Alert 66-40; http://www.accessdata.fda.gov/cms_ia/importalert_189.html). You may submit testimony to provide evidence to overcome the appearance of adulteration. The API source for this finished dosage form drug is:

Refusal History

DateProductViolationsDivision
6/14/2016
62GBA41IBUPROFEN (ANTI-INFLAMMATORY)
118NOT LISTED
3847FDF4APIGMP
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/11/2007
66VDB99MISCELLANEOUS PATENT MEDICINES, ETC.
16DIRECTIONS
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is STRIDES ARCOLAB LIMITED's FDA import refusal history?

STRIDES ARCOLAB LIMITED (FEI: 3004612674) has 2 FDA import refusal record(s) in our database, spanning from 7/11/2007 to 6/14/2016.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. STRIDES ARCOLAB LIMITED's FEI number is 3004612674.

What types of violations has STRIDES ARCOLAB LIMITED received?

STRIDES ARCOLAB LIMITED has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about STRIDES ARCOLAB LIMITED come from?

All FDA import refusal data for STRIDES ARCOLAB LIMITED is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.